Biomarkers Summit (2012)

This Biomarkers Summit 2012 will provide a unique opportunity for debate and problem solving for key challenges facing the biomarkers fields as well as hearing from leading experts in this rapidly-evolving area. Now in its 5th year, this event will present attendees with the latest developments in the field through case-studies and insights from industry leaders in biomarker discovery and development as well as acting as the perfect forum for discussion. With senior industry executives from Pfizer, AstraZeneca, GSK, Merck, Eli Lilly, Johnson & Johnson, Bayer and the FDA all presenting on their current work in a variety of different therapeutic areas; from oncology to immunology and respiratory to neurodegenerative diseases, this year’s conference is not to be missed! The event will provide a complete picture of developments in the biomarkers field, focusing on biomarker development, discovery and validation as well as technological and regulatory updates and will be the ideal opportunity for problem-solving discussion and idea-sharing debate.  Feedback on last year's event included: “It gave me a 360° overview of the research in this field” “A very good networking opportunity and information gathering” “Thank you very much for a great meeting”